4/A

PRIMARY DOCUMENT

Company: SELLAS Life Sciences Group, Inc.
Filed: June 17, 2013
Period of Report: June 4, 2013
Accession Number: 0001250853-13-000079

View Document ↗ View on SEC.gov ↗